Women and heart disease: studies show importance of family history in ID of high-risk patients.
There is new evidence that the most common method for assessing risk of CVD--the Framingham Risk Estimate or FRE--fails to identify a significant number of women who could benefit from aggressive preventive therapies. As a result, investigators are urging clinicians to supplement the FRE with other screening methodologies, at least in some cases.
D005260:Female; D006331:Heart Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D006801:Humans; D012106:Research; D012307:Risk Factors; D016387:Women's Health